| Literature DB >> 35679612 |
Chikako Tange1, Yukiko Nishita1, Makiko Tomida1, Rei Otsuka1, Fujiko Ando1,2, Hiroshi Shimokata1,3, Hidenori Arai4.
Abstract
BACKGROUND: The gap between the average life expectancy and healthy life expectancy remains wide. Understanding the natural history of frailty development is necessary to prevent and treat frailty to overcome this gap. This study elucidated the trajectories of 5 frailty assessment components using group-based multitrajectory modeling.Entities:
Keywords: Five frailty assessment components; Group-based multitrajectory modeling; Longitudinal data; Trajectory groups
Mesh:
Year: 2022 PMID: 35679612 PMCID: PMC9536447 DOI: 10.1093/gerona/glac130
Source DB: PubMed Journal: J Gerontol A Biol Sci Med Sci ISSN: 1079-5006 Impact factor: 6.591
Figure 1.Flow chart of the study participants: The study participants were limited to those aged ≥65 y with at least 3 frailty assessments.
Characteristics of the Participants in Total and According to the Frailty Trajectory Group at Their First Frailty Assessment
| All ( | G1 ( | G2 ( | G3 ( | G4 ( | G5 ( |
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean, | Mean, | Mean, | Mean, | Mean, | Mean, | |||||||||
| Age | 69.7 | 4.5 | 72.4 | 4.6 | 68.6 | 3.9 | 69.6 | 4.3 | 74.7 | 4.2 | 68.7 | 4.2 | 39.87 | <.001 |
| NILS-LSA follow-up period | 7.1 | 2.3 | 7.4 | 2.2 | 6.9 | 2.3 | 7.3 | 2.3 | 7.0 | 2.3 | 7.1 | 2.4 | 1.64 | .163 |
| Sex: males | 433 | (51.2) | 24▼ | (26.1) | 229∆ | (62.1) | 109 | (53.2) | 18▼ | (31.6) | 53 | (43.4) | 52.68 | <.001 |
| Education | 11.1 | 2.7 | 10.3 | 2.2 | 11.6 | 2.8 | 11.0 | 2.5 | 10.5 | 2.7 | 10.9 | 2.4 | 6.09 | <.001 |
| MMSE score (0–30) | 28.1 | 1.7 | 27.8 | 1.8 | 28.2 | 1.7 | 27.9 | 1.8 | 28.0 | 2.0 | 28.0 | 1.7 | 2.11 | .078 |
| Current smoking: yes | 117 | (13.9) | 8 | (8.7) | 42 | (11.4) | 35 | (17.1) | 9 | (15.8) | 23 | (18.9) | 8.40 | .078 |
| Marital status: married | 689 | (81.5) | 72 | (78.3) | 324∆ | (87.8) | 159 | (77.6) | 37▼ | (64.9) | 97 | (79.5) | 23.24 | <.001 |
| Medical history: yes | ||||||||||||||
| Hypertension | 322 | (38.3) | 31 | (34.1) | 118▼ | (32.1) | 88 | (42.9) | 33∆ | (60.0) | 52 | (42.6) | 20.53 | <.001 |
| Dyslipidemia | 185 | (22.0) | 17 | (18.7) | 82 | (22.3) | 48 | (23.4) | 19 | (34.6) | 19 | (15.6) | 8.82 | .066 |
| Diabetes | 73 | (8.7) | 7 | (7.7) | 31 | (8.4) | 21 | (10.2) | 2 | (3.6) | 12 | (9.8) | 2.84 | .586 |
| Cerebrovascular disease | 44 | (5.2) | 5 | (5.5) | 15 | (4.1) | 15 | (7.3) | 7∆ | (12.7) | 2 | (1.6) | 12.25 | .016 |
| Heart disease | 145 | (17.4) | 22 | (24.7) | 56 | (15.3) | 32 | (15.7) | 15 | (26.8) | 20 | (16.7) | 8.29 | .082 |
| Number of frailty components | 0.8 | 0.9 | 1.3 | 1.0 | 0.3 | 0.5 | 1.0 | 0.6 | 1.9 | 1.1 | 1.3 | 0.8 | 118.15 | <.001 |
Notes: MMSE = Mini-Mental State Examination; NILS-LSA = National Institute for Longevity Sciences-Longitudinal Study of Aging. Continuous variables were expressed as means and SD, and intergroup comparisons were made using the general linear model, with post hoc Tukey–Kramer multiple-comparison analysis. Categorical variables were expressed as numbers and percentages, and the χ 2 test was applied, with post hoc residual analysis: The black triangle (downwards) indicates significantly less frequent cases, and the white triangle (upwards) indicates significantly more frequent cases.
*Results of multiple comparisons for age: G2, G5, G3 < G1 < G4.
†Interval between the date of the first and last frailty assessments in the NILS-LSA.
‡Results of multiple comparisons for education: G1, G4 < G2.
§Results of multiple comparisons for the number of frailty components: G2 < G3 < G5, G1 < G4.
Figure 2.Trajectories of the 5 components of frailty by groups: (A) G1: Weakness-focused frail progression group, (B) G2: Robust maintenance group, (C) G3: Exhaustion-focused prefrail group, (D) G4: Frail progression group, and (E) G5: Low activity–focused prefrail group.
Association Between All-Cause Mortality and Frailty Trajectory Group
| Unadjusted model | Adjusted model | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β |
| χ 2 |
| HR | 95% CI | β |
| χ 2 |
| HR | 95% CI | ||
| Frailty trajectory group | G1 | 0.77 | 0.23 | 11.54 | <.001 | 2.15 | 1.38–3.35 | 0.87 | 0.24 | 12.78 | <.001 | 2.38 | 1.48–3.83 |
| G3 | 0.08 | 0.21 | 0.14 | .712 | 1.08 | 0.71–1.65 | 0.08 | 0.21 | 0.14 | .711 | 1.08 | 0.71–1.65 | |
| G4 | 1.16 | 0.23 | 25.09 | <.001 | 3.18 | 2.02–4.99 | 0.84 | 0.25 | 11.09 | <.001 | 2.31 | 1.41–3.78 | |
| G5 | 0.34 | 0.24 | 2.08 | .149 | 1.41 | 0.88–2.25 | 0.55 | 0.24 | 5.18 | .023 | 1.73 | 1.08–2.76 | |
| Sex | Females | −1.20 | 0.17 | 49.27 | <.001 | 0.30 | 0.22–0.42 | ||||||
| Age | 0.12 | 0.02 | 46.41 | <.001 | 1.13 | 1.09–1.17 | |||||||
Notes: CI = confidence interval; HR = hazard ratio. Mean follow-up period (y) ± SD: G1, 13.5 ± 3.5; G2, 13.4 ± 2.7; G3, 14.0 ± 2.7; G4, 13.5 ± 3.5; G5, 13.4 ± 3.1. Number of deceased (%) as of December 31, 2017: G1, 31 (33.7); G2, 54 (14.6); G3, 37 (18.1); G4, 29 (50.9); G5, 26 (21.3).
*Adjusted for sex and age at first frailty assessment.
†Reference group: G2 for the frailty trajectory group; males for sex.
‡Age at first frailty assessment.